Suppr超能文献

环状 RNA 降低免疫原性,并能延长体内翻译时间。

RNA Circularization Diminishes Immunogenicity and Can Extend Translation Duration In Vivo.

机构信息

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.

出版信息

Mol Cell. 2019 May 2;74(3):508-520.e4. doi: 10.1016/j.molcel.2019.02.015. Epub 2019 Mar 19.

Abstract

Circular RNAs (circRNAs) are a class of single-stranded RNAs with a contiguous structure that have enhanced stability and a lack of end motifs necessary for interaction with various cellular proteins. Here, we show that unmodified exogenous circRNA is able to bypass cellular RNA sensors and thereby avoid provoking an immune response in RIG-I and Toll-like receptor (TLR) competent cells and in mice. The immunogenicity and protein expression stability of circRNA preparations are found to be dependent on purity, with small amounts of contaminating linear RNA leading to robust cellular immune responses. Unmodified circRNA is less immunogenic than unmodified linear mRNA in vitro, in part due to the evasion of TLR sensing. Finally, we provide the first demonstration to our knowledge of exogenous circRNA delivery and translation in vivo, and we show that circRNA translation is extended in adipose tissue in comparison to unmodified and uridine-modified linear mRNAs.

摘要

环状 RNA(circRNA)是一类具有连续结构的单链 RNA,具有增强的稳定性和缺乏与各种细胞蛋白相互作用所需的末端基序。在这里,我们表明未经修饰的外源性 circRNA 能够绕过细胞 RNA 传感器,从而避免在 RIG-I 和 Toll 样受体 (TLR) 功能齐全的细胞和小鼠中引发免疫反应。circRNA 制剂的免疫原性和蛋白表达稳定性取决于纯度,少量污染的线性 RNA 会导致强烈的细胞免疫反应。未经修饰的 circRNA 在体外比未经修饰的线性 mRNA 的免疫原性低,部分原因是逃避了 TLR 的感应。最后,我们首次提供了外源性 circRNA 在体内递呈和翻译的证据,并且我们表明与未经修饰和尿嘧啶修饰的线性 mRNA 相比,circRNA 翻译在脂肪组织中得到了延长。

相似文献

1
RNA Circularization Diminishes Immunogenicity and Can Extend Translation Duration In Vivo.
Mol Cell. 2019 May 2;74(3):508-520.e4. doi: 10.1016/j.molcel.2019.02.015. Epub 2019 Mar 19.
2
Sensing Self and Foreign Circular RNAs by Intron Identity.
Mol Cell. 2017 Jul 20;67(2):228-238.e5. doi: 10.1016/j.molcel.2017.05.022. Epub 2017 Jun 15.
4
Synthetic circular RNA switches and circuits that control protein expression in mammalian cells.
Nucleic Acids Res. 2023 Feb 28;51(4):e24. doi: 10.1093/nar/gkac1252.
5
Dynamics of MiRNA Transcriptome in Turbot (Scophthalmus maximus L.) Intestine Following Vibrio anguillarum Infection.
Mar Biotechnol (NY). 2019 Aug;21(4):550-564. doi: 10.1007/s10126-019-09903-z. Epub 2019 May 21.
6
N6-Methyladenosine Modification Controls Circular RNA Immunity.
Mol Cell. 2019 Oct 3;76(1):96-109.e9. doi: 10.1016/j.molcel.2019.07.016. Epub 2019 Aug 29.
8
Characterization of Circular RNAs (circRNA) Associated with the Translation Machinery.
Methods Mol Biol. 2018;1724:159-166. doi: 10.1007/978-1-4939-7562-4_13.
9
Possible epigenetic regulatory effect of dysregulated circular RNAs in epilepsy.
PLoS One. 2018 Dec 28;13(12):e0209829. doi: 10.1371/journal.pone.0209829. eCollection 2018.

引用本文的文献

1
The potential and challenges of circular RNA in the development of vaccines and drugs for emerging infectious diseases.
Mol Ther Nucleic Acids. 2025 Aug 14;36(3):102687. doi: 10.1016/j.omtn.2025.102687. eCollection 2025 Sep 9.
2
Challenges and Future Prospectives in Circular RNA Investigation.
Adv Exp Med Biol. 2025;1485:467-479. doi: 10.1007/978-981-96-9428-0_27.
3
Circular RNAs in Immune-Related Diseases.
Adv Exp Med Biol. 2025;1485:417-435. doi: 10.1007/978-981-96-9428-0_24.
4
Circular RNAs in Organ Fibrosis.
Adv Exp Med Biol. 2025;1485:329-347. doi: 10.1007/978-981-96-9428-0_19.
5
CircRNA Synthesis and Applications.
Adv Exp Med Biol. 2025;1485:241-252. doi: 10.1007/978-981-96-9428-0_16.
6
Exploring the Potential and Advancements of Circular RNA Therapeutics.
Exploration (Beijing). 2025 May 1;5(4):e20240044. doi: 10.1002/EXP.20240044. eCollection 2025 Aug.
7
Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics.
Vaccines (Basel). 2025 Jul 31;13(8):821. doi: 10.3390/vaccines13080821.
8
Mechanistic insights into circularization via group I intron-based scarless circular RNA.
Mol Ther Nucleic Acids. 2025 Jul 17;36(3):102626. doi: 10.1016/j.omtn.2025.102626. eCollection 2025 Sep 9.
9
CircRNAs: functions and emerging roles in cancer and immunotherapy.
BMC Med. 2025 Aug 15;23(1):477. doi: 10.1186/s12916-025-04306-5.
10
Self-splicing RNA circularization facilitated by intact group I and II introns.
Nat Commun. 2025 Aug 10;16(1):7376. doi: 10.1038/s41467-025-62607-y.

本文引用的文献

1
Engineering circular RNA for potent and stable translation in eukaryotic cells.
Nat Commun. 2018 Jul 6;9(1):2629. doi: 10.1038/s41467-018-05096-6.
2
Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3351-E3360. doi: 10.1073/pnas.1720542115. Epub 2018 Mar 27.
3
Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Genome Med. 2017 Jun 27;9(1):60. doi: 10.1186/s13073-017-0450-0.
4
Sensing Self and Foreign Circular RNAs by Intron Identity.
Mol Cell. 2017 Jul 20;67(2):228-238.e5. doi: 10.1016/j.molcel.2017.05.022. Epub 2017 Jun 15.
5
Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis.
Mol Cell. 2017 Apr 6;66(1):22-37.e9. doi: 10.1016/j.molcel.2017.02.017. Epub 2017 Mar 23.
7
Extensive translation of circular RNAs driven by N-methyladenosine.
Cell Res. 2017 May;27(5):626-641. doi: 10.1038/cr.2017.31. Epub 2017 Mar 10.
8
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.
Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5.
9
Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.
Immunity. 2016 Oct 18;45(4):737-748. doi: 10.1016/j.immuni.2016.09.011. Epub 2016 Oct 11.
10
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.
Biomaterials. 2016 Dec;109:78-87. doi: 10.1016/j.biomaterials.2016.09.006. Epub 2016 Sep 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验